- Home
- YDES
as of 10-21-2026 3:55pm EST
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
| Founded: | 2013 | Country: | Taiwan |
| Employees: | N/A | City: | N/A |
| Market Cap: | 476.8M | IPO Year: | 2024 |
| Target Price: | N/A | AVG Volume (30 days): | 380.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $1.70 - $18.57 | Next Earning Date: | 08-31-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
AI-Powered YDES Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of YD Bio Limited Ordinary Shares (YDES)
CEO
Avg Cost/Share
$3.93
Shares
3,100
Total Value
$12,183.00
Owned After
11,245,631
SEC Form 4
CEO
Avg Cost/Share
$3.67
Shares
18,378
Total Value
$67,447.26
Owned After
11,245,631
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Shen Ethan PhD | YDES | CEO | Sep 9, 2026 | Buy | $3.93 | 3,100 | $12,183.00 | 11,245,631 | |
| Shen Ethan PhD | YDES | CEO | Sep 4, 2026 | Buy | $3.67 | 18,378 | $67,447.26 | 11,245,631 |
Compare YDES vs Leading Stocks
See how YDES stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "YDES YD Bio Limited Ordinary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.